Founded in Harare, Zimbabwe
Varichem Pharmaceuticals is established with a mission to provide locally manufactured, high-quality medicines to support Zimbabwe's growing healthcare needs.
Forty years in the making
Built patiently. Proven when it mattered.
From generating seed capital through brake fluid to becoming Southern Africa's first indigenous pharmaceutical manufacturer with WHO-prequalified ARVs, Varichem's story is one of resolve, reinvention, and local capability.
Four decades in motion
1985 — 2025
1985
Founded in Harare
2004
First locally made ARVs
2010
WHO prequalification
2025
Four decades of impact
The long view
Eight eras that shaped Varichem.
1985.
Inception
1990s.
Growth
Product Expansion & Facility Growth
The company expands its portfolio to include a wide range of generic medicines, topical creams, and oral liquids, becoming a reliable supplier to local hospitals and pharmacies.
2004.
ARVs Launch
Launch of Locally Made ARVs
Varichem becomes the first local pharmaceutical company in Zimbabwe to produce antiretroviral drugs (ARVs). It launches Stalanev, the country's first triple-combination ARV — a major breakthrough in HIV/AIDS treatment accessibility.
2010.
WHO Prequalification
WHO Prequalification Achieved
Varichem earns World Health Organization (WHO) prequalification for its ARVs — specifically Stalanev 30 and Varivar — making it the first indigenous pharmaceutical company in Southern Africa to meet global quality standards. This enables participation in international donor-funded programs.
2011 – 2015.
Regional Market
Regional Market Entry
The company begins exporting to neighboring countries including Malawi, Zambia, Botswana, and Mozambique, expanding its footprint in Southern Africa and supporting regional healthcare systems.
2016 – 2020.
Compliance
Infrastructure & Compliance Upgrades
Varichem invests in state-of-the-art manufacturing equipment and upgrades its Quality Control Laboratory to align with evolving GMP, ISO, and regulatory standards, reinforcing its reputation for excellence.
2020 – 2024.
Resilience
Resilience During COVID-19
Despite global supply chain disruptions, Varichem maintains uninterrupted medicine production, supporting national health resilience and continuing to serve public sector and donor-funded procurement systems.
2025.
40th Anniversary
Celebrating 40 Years of Impact
Today, Varichem offers 178+ registered medicines, operates a GMP-certified facility, and is recognized as one of Zimbabwe's most trusted pharmaceutical manufacturers — with a legacy of innovation, integrity, and regional impact.
The next chapter
The legacy is established. The work continues.
Varichem enters its fifth decade focused on deeper regional reach, stronger local capability, and accessible medicines for the communities it serves.
Build the next chapter with us